These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The agents of human viral hepatitis, and control of the disease. Deinhardt F Prog Med Virol; 1984; 30():14-28. PubMed ID: 6087411 [No Abstract] [Full Text] [Related]
27. Antigenic specificity of porcine T cell response against foot-and-mouth disease virus structural proteins: identification of T helper epitopes in VP1. Rodríguez A; Sáiz JC; Novella IS; Andreu D; Sobrino F Virology; 1994 Nov; 205(1):24-33. PubMed ID: 7526534 [TBL] [Abstract][Full Text] [Related]
29. Formation of immunogenic virus-like particles by inserting epitopes into surface-exposed regions of hamster polyomavirus major capsid protein. Gedvilaite A; Frömmel C; Sasnauskas K; Micheel B; Ozel M; Behrsing O; Staniulis J; Jandrig B; Scherneck S; Ulrich R Virology; 2000 Jul; 273(1):21-35. PubMed ID: 10891404 [TBL] [Abstract][Full Text] [Related]
30. Hepatitis A virus: clones, cultures, and vaccines. Ticehurst JR Semin Liver Dis; 1986 Feb; 6(1):46-55. PubMed ID: 3012783 [No Abstract] [Full Text] [Related]
31. Controlled conformational transitions in the MVM virion expose the VP1 N-terminus and viral genome without particle disassembly. Cotmore SF; D'abramo AM; Ticknor CM; Tattersall P Virology; 1999 Feb; 254(1):169-81. PubMed ID: 9927584 [TBL] [Abstract][Full Text] [Related]
32. [A model of the secondary structure and distribution of antigenic determinants in the VP1 protein of hepatitis A virus]. Mesianzhinov VV Biofizika; 1986; 31(6):961-3. PubMed ID: 2432945 [TBL] [Abstract][Full Text] [Related]
33. [Hepatitis serology: use and interpretation]. Grob PJ Ther Umsch; 1992 May; 49(5):287-301. PubMed ID: 1377839 [TBL] [Abstract][Full Text] [Related]
34. Hepatitis A virus: insights from molecular biology. Cohen JI Hepatology; 1989 Jun; 9(6):889-95. PubMed ID: 2541060 [No Abstract] [Full Text] [Related]
35. Antigenic relatedness of two strains of hepatitis A virus determined by cross-neutralization. Lemon SM; Binn LN Infect Immun; 1983 Oct; 42(1):418-20. PubMed ID: 6194118 [TBL] [Abstract][Full Text] [Related]
36. [Approaches to the design of antiviral vaccines (a theoretical review)]. Dzagurov SG; Gnuni GM; Khvoles AG Vopr Virusol; 1984; 29(2):137-40. PubMed ID: 6203226 [No Abstract] [Full Text] [Related]
37. Are there antigenic variants of hepatitis A virus? Stakhanova VM; Vyazov SO; Doroshenko NV; Zairov GK; Ananiev VA; Zhdanov VM Lancet; 1979 Sep; 2(8143):631-2. PubMed ID: 90289 [No Abstract] [Full Text] [Related]
38. [Do antigenic variants of the hepatitis A virus exist?]. Stakhanova VM; Viazov SO; Doroshenko NV; Zairov GK; Anan'ev VA Vopr Virusol; 1979; (5):558-9. PubMed ID: 228499 [No Abstract] [Full Text] [Related]
39. Biological and molecular comparisons of human (HM-175) and simian (AGM-27) hepatitis A viruses. Emerson SU; Tsarev SA; Purcell RH J Hepatol; 1991; 13 Suppl 4():S144-5. PubMed ID: 1668325 [TBL] [Abstract][Full Text] [Related]
40. Genomic classification and genetic relationships of a new variant of hepatitis A virus isolated in Cuba. Díaz BI; Sariol CA; Martínez R; Rodríguez L Mem Inst Oswaldo Cruz; 1999; 94(3):361-3. PubMed ID: 10348982 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]